耐多药结核病临床研究的回顾与展望

被引：23

作者：

高振秋 ^{[1
]}

王东方 ^{[2
]}

任成山 ^{[3
]}

机构：

[1] 中国人民解放军第医院内科

[2] 陕西省广播电视局机关门诊部内科

[3] 第三军医大学新桥医院

来源：

中华肺部疾病杂志(电子版) | 2010年 / 3卷 / 05期

关键词：

耐多药结核病; 广泛耐药结核病; 临床研究; 回顾与展望;

D O I：

暂无

中图分类号：

R52 [结核病];

学科分类号：

100201 [内科学];

摘要：

引用

页码：353 / 363

页数：11

共 24 条

[1]

New anti-tuberculosis drugs in clinical trials with novel mechanisms of action.[J].Emma C. Rivers;Ricardo L. Mancera.Drug Discovery Today.2008, 23

[2]

Development of new antituberculous agents based on new drug targets and structure–activity relationship.[J].Tomioka.Expert Opinion on Drug Discovery.2008, 1

[3]

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa [J].

Gandhi, Neel R. ;

Moll, Anthony ;

Sturm, A. Willem ;

Pawinski, Robert ;

Govender, Thiloshini ;

Lalloo, Umesh ;

Zeller, Kimberly ;

Andrews, Jason ;

Friedland, Gerald .

LANCET, 2006, 368 (9547) :1575-1580

[4]

Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study [J].

Leimane, V ;

Riekstina, V ;

Holtz, TH ;

Zarovska, E ;

Skripconoka, V ;

Thorpe, LE ;

Laserson, KF ;

Wells, CD .

LANCET, 2005, 365 (9456) :318-326

[5]

New drugs for tuberculosis: Current status and future prospects [J].

O'Brien, RJ ;

Spigelman, M .

CLINICS IN CHEST MEDICINE, 2005, 26 (02) :327-+

[6]

Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical strains isolated in the Philippines [J].

Herrera, L ;

Valverde, A ;

Saiz, P ;

Sáez-Nieto, JA ;

Portero, JL ;

Jiménez, MS .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 23 (06) :572-576

[7]

Accurate mapping of mutations of pyrazinamide-resistant Mycobacterium tuberculosis strains with a scanning-frame oligonucleotide microarray [J].

Wade, MM ;

Volokhov, D ;

Peredelchuk, M ;

Chizhikov, V ;

Zhang, Y .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 49 (02) :89-97

[8]

Detection of rifampin-resistant Mycobacterium tuberculosis strains by using a specialized oligonucleotide microarray [J].

Yue, J ;

Shi, W ;

Xie, JP ;

Li, Y ;

Zeng, EL ;

Liang, L ;

Wang, HH .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 48 (01) :47-54

[9]

The global situation of MDR-TB.[J].Marcos A. Espinal.Tuberculosis.2003, 1

[10]

Ketolides - telithromycin, an example of a new class of antibacterial agents [J].

Bryskier, A .

CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (12) :661-669

← 1 2 3 →